Premier Biomedical Inc
OTC:BIEI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Premier Biomedical Inc
Free Cash Flow
Premier Biomedical Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Premier Biomedical Inc
OTC:BIEI
|
Free Cash Flow
-$349.1k
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Free Cash Flow
$17.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
10%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Free Cash Flow
$9.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Free Cash Flow
$8.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Free Cash Flow
$3.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Free Cash Flow
$3.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
19%
|
|
Premier Biomedical Inc
Glance View
Premier Biomedical, Inc. is a research-based company, which engages in the development and discovery of medical products. The company is headquartered in Whitefish, Montana. The company went IPO on 2012-02-23. The firm has developed a line of topical hemp oil pain relief products. The firm develops medical treatments for humans, specifically focusing on the treatment of Cancer Fibromyalgia, Traumatic Brain Injury (TBI), Alzheimer’s Disease (AD), Blood Sepsis and Viremia, Feldetrex. The firm offers eight pain relief products: 96-hour pain relief patch with 50 mg of hemp oil extract, 120 milligram (mg)/ 10 milliliter (ml) water-based roll-on applicator; 150 mg/ 30 ml oil-based pump spray applicator; 150 mg/ 2 oz. ointment; 200 mg/10 ml oil-based roll-on applicator; 500 mg/ 30 ml oil-based pump-spray applicator, and 500 mg/ 1 oz. ointment. The company offers extra-corporeal treatment of disease, PTSD treatment, anti-breast cancer drugs, hemp oil, anti-aging treatments and chemical and alcohol addiction treatment.
See Also
What is Premier Biomedical Inc's Free Cash Flow?
Free Cash Flow
-349.1k
USD
Based on the financial report for Dec 31, 2019, Premier Biomedical Inc's Free Cash Flow amounts to -349.1k USD.
What is Premier Biomedical Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
11%
Over the last year, the Free Cash Flow growth was 22%. The average annual Free Cash Flow growth rates for Premier Biomedical Inc have been 11% over the past three years , 11% over the past five years .
